| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $24,492,141 ) (Continued on the next page) |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM155098 | Interplay between DNA base excision repair and transcriptional regulation | 000 | 3 | NIH | 8/11/2026 | $470,000 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA307511 | Intratumor Heterogeneity as a Correlate of Clinical Outcome in Patients Avoiding Radical Cystectomy | 000 | 1 | NIH | 4/3/2026 | $766,439 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD018146 | Examining the Relationship between Residential History at Midlife and Prostate Cancer Outcomes | 002 | 4 | NIH | 8/10/2026 | $0 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD018146 | Examining the Relationship between Residential History at Midlife and Prostate Cancer Outcomes | 000 | 4 | NIH | 8/4/2026 | $1,026,619 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00CA267678 | Positive Activities for Asian American Cancer Patients and Caregivers | 000 | 5 | NIH | 3/30/2026 | $249,000 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | P01AI102853 | Molecular Basis for γδ T Lineage Specification | 001 | 12 | NIH | 8/19/2026 | $2,351,288 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA289703 | Hepatic Tissue Integrity and Clonal Fitness: Key Factors in Controlling β-Catenin Induced Oncogenesis | 001 | 3 | NIH | 8/3/2026 | $0 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA289703 | Hepatic Tissue Integrity and Clonal Fitness: Key Factors in Controlling β-Catenin Induced Oncogenesis | 000 | 3 | NIH | 2/27/2026 | $523,854 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA281212 | Elucidating the critical role of Wee1 in GIST | 000 | 4 | NIH | 2/27/2026 | $430,050 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UH3HL170034 | Asian American Community Cohort and Engagement Study (ACCESS) | 001 | 4 | NIH | 8/10/2026 | $474,106 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UH3HL170034 | Asian American Community Cohort and Engagement Study (ACCESS) | 001 | 4 | NIH | 8/10/2026 | $44,187 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UH3HL170034 | Asian American Community Cohort and Engagement Study (ACCESS) | 001 | 4 | NIH | 8/10/2026 | $44,187 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UH3HL170034 | Asian American Community Cohort and Engagement Study (ACCESS) | 001 | 4 | NIH | 8/10/2026 | $43,303 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UH3HL170034 | Asian American Community Cohort and Engagement Study (ACCESS) | 001 | 4 | NIH | 8/10/2026 | $43,303 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21CA296696 | Assessment of Efficacy and Toxicity of T3 for Medulloblastoma Treatment | 001 | 2 | NIH | 4/17/2026 | $26,422 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21CA296696 | Assessment of Efficacy and Toxicity of T3 for Medulloblastoma Treatment | 000 | 2 | NIH | 1/27/2026 | $237,809 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UH3CA271230 | Validation of blood-based predictive biomarkers of therapeutic response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer | 000 | 5 | NIH | 7/23/2026 | $470,000 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R37CA283552 | Targeting DHX9 to trigger viral mimicry and immunotherapy responsiveness in Small Cell Lung Cancer (SCLC) | 000 | 3 | NIH | 7/15/2026 | $649,679 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R37AI110985 | Regulation of hematopoiesis by ribosomal protein paralogs | 000 | 12 | NIH | 1/29/2026 | $684,005 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA283396 | Divergent Functions of ERK Substrate Binding Domains in Pathogenesis of Myeloproliferative Neoplasms | 000 | 4 | NIH | 7/3/2026 | $708,730 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00DK128602 | Defining the molecular basis controlling hematopoietic stem cell symmetric and asymmetric divisions | 000 | 5 | NIH | 8/17/2026 | $249,000 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA282766 | Interrogating MRCK Protein Kinases in Ovarian Cancer | 000 | 3 | NIH | 2/26/2026 | $408,139 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD017675 | Reducing Urban Cervical Cancer Disparities Using a Tailored mHealth Intervention to Enhance Colposcopy Attendance | 001 | 4 | NIH | 4/3/2026 | $69,206 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD017675 | Reducing Urban Cervical Cancer Disparities Using a Tailored mHealth Intervention to Enhance Colposcopy Attendance | 000 | 4 | NIH | 1/26/2026 | $622,860 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM150538 | Telomerase RNP Prisonbreaks from Phase-Separated Nuclear Body | 000 | 4 | NIH | 5/22/2026 | $470,000 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA276273 | Fibroblasts Support the Growth of Brain Metastasis by Rendering Cancer Cells Resistant to Chemotherapy and Inducing Immunosuppression in Tumor Microenvironment | 000 | 4 | NIH | 5/5/2026 | $412,500 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA271915 | Targeting the BCL2 immune checkpoint to enhance the immunostimulatory effects of radiation in breast cancer | 000 | 5 | NIH | 8/5/2026 | $778,724 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | U54CA272686 | Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center | 000 | 5 | NIH | 8/17/2026 | $1,231,641 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01AI171568 | Role of ZBP1 in pathogenesis of Salmonella biofilms | 000 | 4 | NIH | 4/28/2026 | $834,784 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA269975 | Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy | 001 | 4 | NIH | 4/16/2026 | $75,897 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA269975 | Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy | 000 | 4 | NIH | 12/30/2025 | $683,088 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA269660 | Pancreatic cancer-associated fibroblasts: function, detection, and regulation | 000 | 5 | NIH | 6/16/2026 | $520,918 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R25CA259244 | Empowering the Next Generation of Cancer Professionals: the Fox Chase Cancer Center-University of Delaware Partnership for Undergraduate Research and Career Development | 001 | 5 | NIH | 3/2/2026 | $151,638 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM144131 | Deciphering Networks Controlling DNA Amplification | 001 | 5 | NIH | 3/11/2026 | $46,750 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM144131 | Deciphering Networks Controlling DNA Amplification | 000 | 5 | NIH | 12/9/2025 | $420,750 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00CA276888 | Mechanisms and vulnerabilities of ERG-driven luminal fate in prostate cancer | 000 | 4 | NIH | 4/29/2026 | $249,000 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA290043 | Thyroid Hormone Inhibits Medulloblastoma Growth by Inducing Tumor Cell Differentiation | 000 | 2 | NIH | 5/5/2026 | $423,523 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 001 | 57 | NIH | 6/26/2026 | $2,784,349 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA279117 | Interrogating Type I Interferon signaling in breast cancer brain metastasis | 000 | 3 | NIH | 4/29/2026 | $546,142 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD018511 | Neighborhood, social connectedness, and allostatic load | 001 | 4 | NIH | 2/22/2026 | $66,691 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD018511 | Neighborhood, social connectedness, and allostatic load | 000 | 4 | NIH | 1/12/2026 | $600,215 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA289629 | Targeting anoctamin 6 to disrupt trogocytosis of cancer-associated fibroblasts | 000 | 2 | NIH | 2/25/2026 | $642,755 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM122517 | Structural Bioinformatics of Proteins and Protein Complexes and Applications to Cancer Biology | 000 | 9 | NIH | 4/17/2026 | $744,480 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM119560 | Molecular Mechanisms Underlying Adaptor-Mediated Integrin Signaling in a Species-Specific Manner | 001 | 10 | NIH | 3/20/2026 | $48,152 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM119560 | Molecular Mechanisms Underlying Adaptor-Mediated Integrin Signaling in a Species-Specific Manner | 000 | 10 | NIH | 12/16/2025 | $433,373 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM154879 | Mechanistic Studies of Genome Folding | 000 | 3 | NIH | 5/7/2026 | $470,000 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA262551 | Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis | 000 | 5 | NIH | 5/7/2026 | $570,865 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UH2CA299386 | Clinical Translation of a Urine-Based Biomarker for the Detection of Residual Disease in Radical Cystectomy Candidates | 000 | 1 | NIH | 5/14/2026 | $263,670 |
| | 2026 | 2026 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA262466 | Assessing DNA polymerase theta as a therapeutic target in BRCA1 mutant cancer | 000 | 5 | NIH | 2/25/2026 | $430,050 |
|
